Skip to main content
Year archive

Galapagos NV — 2021 filings

All 183 regulatory filings released by Galapagos NV (GLPG) in 2021, sourced directly from the official regulator.

183 Filings
2021 Period
2021 filings (183)
Filing Released Lang
Galapagos increases share capital through subscription right exercises
Share Issue/Capital Change
2021-12-06 Dutch
Galapagos increases share capital through subscription right exercises
Share Issue/Capital Change
2021-12-06 English
6-K Filing
Foreign Filer Report
2021-12-06 English
Galapagos increases share capital through subscription right exercises.pdf
Share Issue/Capital Change
2021-12-04 English
Galapagos verhoogt kapitaal door uitoefening van inschrijvingsrechten.pdf
Share Issue/Capital Change
2021-12-04 Dutch
6-K Filing
Foreign Filer Report
2021-11-29 English
Galapagos completes patient recruitment for MANGROVE Phase 2 trial with GLPG2737 in polycystic kidney disease
Earnings Release Q4 2021
2021-11-23 English
Galapagos completes patient recruitment for MANGROVE Phase 2 trial with GLPG2737 in polycystic kidney disease
Regulatory Filings
2021-11-23 English
6-K Filing
Foreign Filer Report
2021-11-17 English
Jyseleca®?(filgotinib) approved in the European Union for the treatment of ulcerative colitis
Earnings Release Q4 2021
2021-11-16 English
Jyseleca®?(filgotinib) approved in the European Union for the treatment of ulcerative colitis
Earnings Release Q4 2021
2021-11-16 English
6-K Filing
Foreign Filer Report
2021-11-08 English
Galapagos reports commercial and operational progress at Q3 financial results
Earnings Release 9M 2021
2021-11-05 English
Galapagos reports commercial and operational progress at Q3 financial results
Earnings Release 9M 2021
2021-11-05 Dutch
Galapagos reports commercial and operational progress at Q3 financial results .pdf
Earnings Release 9M 2021
2021-11-04 English
Galapagos rapporteert commerciële en operationele voortgang bij derde kwartaalresultaten.pdf
Earnings Release 9M 2021
2021-11-04 Dutch
nxr_glpg_q321_en_FINAL_211104-1900.pdf
Interim / Quarterly Report 9M 2021
2021-11-04 English
nxr_glpg_q321_nl_FINAL_211104-1900.pdf
Interim / Quarterly Report 9M 2021
2021-11-04 Dutch
SC 13D Filing
Major Shareholding Notification
2021-11-02 English
S-8 Filing
Registration Form
2021-10-26 English
6-K Filing
Foreign Filer Report
2021-10-06 English
6-K Filing
Foreign Filer Report
2021-10-06 English
Galapagos presenteert nieuwe data van het SELECTION fase 3-programma op het 2021 congres van de United European Gastroenterology Week (UEGW)
Regulatory Filings
2021-10-05 Dutch
Galapagos presenteert nieuwe data van het SELECTION fase 3-programma op het 2021 congres van de United European Gastroenterology Week (UEGW)
Regulatory Filings
2021-10-05 Dutch
Galapagos presenteert nieuwe data van het SELECTION fase 3-programma op het 2021 congres van de United European Gastroenterology Week (UEGW)
Regulatory Filings
2021-10-05 Dutch
Galapagos presenteert nieuwe data van het SELECTION fase 3-programma op het 2021 congres van de United European Gastroenterology Week (UEGW)
Earnings Release Q4 2021
2021-10-05 Dutch
"Galapagos announces completion of patient enrollment for DIVERSITY Phase 3 study with filgotinib in Crohn’s Disease
Regulatory Filings
2021-10-04 Dutch
"Galapagos announces completion of patient enrollment for DIVERSITY Phase 3 study with filgotinib in Crohn’s Disease
Regulatory Filings
2021-10-04 Dutch
Galapagos increases share capital through subscription right exercises
Share Issue/Capital Change
2021-09-21 English
Galapagos increases share capital through subscription right exercises
Share Issue/Capital Change
2021-09-21 English
6-K Filing
Foreign Filer Report
2021-09-21 English
Q3 Share capital increase_EN.pdf
Share Issue/Capital Change
2021-09-20 English
Q3 Share Capital Increase_NL.pdf
Share Issue/Capital Change
2021-09-20 Dutch
6-K Filing
Foreign Filer Report
2021-09-20 English
GALAPAGOS ANNOUNCES POSITIVE CHMP OPINION FOR JYSELECA® (FILGOTINIB) FOR THE TREATMENT OF ADULTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
Earnings Release Q3 2021
2021-09-17 English
GALAPAGOS ANNOUNCES POSITIVE CHMP OPINION FOR JYSELECA® (FILGOTINIB) FOR THE TREATMENT OF ADULTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS
Earnings Release Q3 2021
2021-09-17 English
Galapagos announces planned retirement of CEO
Board/Management Information
2021-08-31 English
Galapagos announces planned retirement of CEO
Board/Management Information
2021-08-31 English
6-K Filing
Foreign Filer Report
2021-08-31 English
Galapagos announces planned retirement of CEO
Board/Management Information
2021-08-30 English
Galapagos kondigt gepland pensioen aan van CEO
Board/Management Information
2021-08-30 Dutch
Galapagos reports H1 financial results with refocused pipeline and operational progress
Interim / Quarterly Report H1 2021
2021-08-06 English
Galapagos reports H1 financial results with refocused pipeline and operational progress
Interim / Quarterly Report H1 2021
2021-08-06 English
Galapagos reports H1 financial results with refocused pipeline and operational progress.pdf
Interim / Quarterly Report H1 2021
2021-08-05 English
Galapagos rapporteert financiële resultaten eerste halfjaar met geheroriënteerde pijplijn en operationele voortgang.pdf
Interim / Quarterly Report H1 2021
2021-08-05 Dutch
H1 report 2021.pdf
Interim / Quarterly Report H1 2021
2021-08-05 English
Halfjaarverslag 2021.pdf
Interim / Quarterly Report H1 2021
2021-08-05 Dutch
6-K Filing
Foreign Filer Report
2021-08-05 English
Galapagos demonstrates early clinical activity with SIK2/3 inhibition in inflammation
Earnings Release Q2 2021
2021-07-15 English
Galapagos demonstrates early clinical activity with SIK2/3 inhibition in inflammation
Earnings Release Q2 2021
2021-07-15 English
Galapagos reports positive topline results with selective TYK2 inhibitor GLPG3667 in Phase 1b psoriasis study
Earnings Release Q3 2021
2021-07-15 English
Galapagos reports positive topline results with selective TYK2 inhibitor GLPG3667 in Phase 1b psoriasis study
Regulatory Filings
2021-07-15 English
Galapagos demonstrates early clinical activity with SIK2/3 inhibition in inflammation
Earnings Release Q2 2021
2021-07-14 English
Galapagos toont vroege klinische activiteit aan met SIK2/3-remmer bij ontstekingsziekten
Regulatory Filings
2021-07-14 Dutch
Galapagos reports positive topline results with selective TYK2 inhibitor GLPG3667 in Phase 1b psoriasis study
Regulatory Filings
2021-07-14 English
Galapagos meldt positieve resultaten met selectieve TYK2-remmer GLPG3667 in fase 1b-studie in psoriasis
Earnings Release Q3 2021
2021-07-14 Dutch
6-K Filing
Foreign Filer Report
2021-07-14 English
6-K Filing
Foreign Filer Report
2021-07-14 English
Galapagos announces new data supporting rapid symptom improvement and sustained steroid-free remission with filgotinib in patients with Ulcerative Colitis
Earnings Release Q3 2021
2021-07-12 English
Galapagos announces new data supporting rapid symptom improvement and sustained steroid-free remission with filgotinib in patients with Ulcerative Colitis
Earnings Release Q3 2021
2021-07-12 English
6-K Filing
Foreign Filer Report
2021-07-12 English
Galapagos kondigt vertrek van Chief Scientific Officer Piet Wigerinck aan later dit jaar
Board/Management Information
2021-06-23 Dutch
Galapagos kondigt vertrek van Chief Scientific Officer Piet Wigerinck aan later dit jaar
Board/Management Information
2021-06-23 Dutch
Galapagos announces departure of CSO Piet Wigerinck later this year
Board/Management Information
2021-06-23 English
Galapagos announces departure of CSO Piet Wigerinck later this year
Board/Management Information
2021-06-23 English
6-K Filing
Foreign Filer Report
2021-06-23 English
Galapagos announces departure of CSO Piet Wigerinck later this year
Board/Management Information
2021-06-22 English
Galapagos kondigt vertrek van Chief Scientific Officer Piet Wigerinck aan later dit jaar
Board/Management Information
2021-06-22 Dutch
Galapagos increases share capital through subscription right exercises
Share Issue/Capital Change
2021-06-08 English
Galapagos increases share capital through subscription right exercises
Share Issue/Capital Change
2021-06-08 English
6-K Filing
Foreign Filer Report
2021-06-08 English
Share capital increase - 7 June 2021 - EN - FINAL.pdf
Share Issue/Capital Change
2021-06-07 English
Share Capital Increase - 7 juni 2021 - NL - finaal.pdf
Share Issue/Capital Change
2021-06-07 Dutch
SELECTION study on filgotinib in ulcerative colitis published in The Lancet
Regulatory Filings
2021-06-04 English
SELECTION study on filgotinib in ulcerative colitis published in The Lancet
Earnings Release Q2 2021
2021-06-04 English
6-K Filing
Foreign Filer Report
2021-06-04 English
Galapagos to present data on rheumatoid arthritis at the upcoming European League Against Rheumatism (EULAR) congress
Environmental & Social Information
2021-05-28 English
Galapagos to present data on rheumatoid arthritis at the upcoming European League Against Rheumatism (EULAR) congress
Regulatory Filings
2021-05-28 English
6-K Filing
Foreign Filer Report
2021-05-28 English
Galapagos announces first patient enrolled in FILOSOPHY study to advance understanding of Jyseleca (filgotinib) effectiveness and safety in a real-world setting
Regulatory Filings
2021-05-19 English
Galapagos announces first patient enrolled in FILOSOPHY study to advance understanding of Jyseleca (filgotinib) effectiveness and safety in a real-world setting
Regulatory Filings
2021-05-19 English
6-K Filing
Foreign Filer Report
2021-05-19 English
6-K Filing
Foreign Filer Report
2021-05-11 English
SC 13G/A Filing
Major Shareholding Notification
2021-05-10 English
Galapagos refocuses pipeline and rightsizes operations
Interim / Quarterly Report Q1 2021
2021-05-07 English
Galapagos refocuses pipeline and rightsizes operations
Interim / Quarterly Report Q1 2021
2021-05-07 English
Galapagos refocuses pipeline and rightsizes operations.pdf
Interim / Quarterly Report Q1 2021
2021-05-06 English
Galapagos heroriënteert pijplijn en stroomlijnt organisatie.pdf
Interim / Quarterly Report Q1 2021
2021-05-06 Dutch
Q1 2021 report.pdf
Interim / Quarterly Report Q1 2021
2021-05-06 English
Verslag eerste kwartaal 2021.pdf
Interim / Quarterly Report Q1 2021
2021-05-06 Dutch
Transparency notification received from The Capital Group
Major Shareholding Notification
2021-05-05 English
Transparency notification received from The Capital Group
Major Shareholding Notification
2021-05-05 English
6-K Filing
Foreign Filer Report
2021-05-05 English
TR1_Galapagos NV_2021 04 29_Issuer_Signed.pdf
Director's Dealing
2021-05-04 English
Transparency notification received from The Capital Group.pdf
Declaration of Voting Results & Voting Rights Announcements
2021-05-04 English
Transparantieverklaring ontvangen van The Capital Group.pdf
Major Shareholding Notification
2021-05-04 Dutch
Galapagos creates new subscription right plans
Share Issue/Capital Change
2021-05-03 English
Galapagos creates new subscription right plans
Share Issue/Capital Change
2021-05-03 English
6-K Filing
Foreign Filer Report
2021-05-03 English
Subscription Right Plan 2021_Supervisory Board Report_7_180-7_191_English_ Website(416740.1).pdf
Remuneration Information
2021-04-30 English
Subscription Right Plan 2021_Supervisory board Report_7_180-7_191_Dutch_Website(416743.1).pdf
Share Issue/Capital Change
2021-04-30 Dutch
6-K Filing
Foreign Filer Report
2021-04-29 English
AGM 2021 Minutes (ENG) (final) - Website(416947.1).pdf
AGM Information
2021-04-28 English
AGM 2021 Minutes (NL) (final) - Website(416948.1).pdf
AGM Information
2021-04-28 Dutch
Gilead Sciences submits new drug application in Japan for filgotinib for the treatment of ulcerative colitis with an inadequate response to conventional therapies
Regulatory Filings
2021-04-23 English
Gilead Sciences submits new drug application in Japan for filgotinib for the treatment of ulcerative colitis with an inadequate response to conventional therapies
Regulatory Filings
2021-04-23 English
6-K Filing
Foreign Filer Report
2021-04-23 English
Extension of lock-up period in Gilead-Galapagos collaboration agreement
Regulatory Filings
2021-04-09 English
Extension of lock-up period in Gilead-Galapagos collaboration agreement
Share Issue/Capital Change
2021-04-09 English
6-K Filing
Foreign Filer Report
2021-04-09 English
Publication of the annual report and invitation to the ordinary shareholders’ meeting
AGM Information
2021-03-26 English
6-K Filing
Foreign Filer Report
2021-03-26 English
Statutory annual accounts Galapagos NV.PDF
Audit Report / Information FY 2020
2021-03-25 Dutch
Attendance Form_final (EN and NL).pdf
AGM Information
2021-03-25 Dutch
AR-Galapagos-Mandate-31Dec2020-NL.pdf
Audit Report / Information FY 2020
2021-03-25 Dutch
Proxy Form_Final.pdf
AGM Information
2021-03-25 Dutch
Overview Voting Rights_Final (EN and NL).pdf
Share Issue/Capital Change
2021-03-25 Dutch
AR-Galapagos-Mandate-31Dec2020-ENG.pdf
Audit Report / Information FY 2020
2021-03-25 English
Vote by Letter Form_Final (EN and NL).pdf
AGM Information
2021-03-25 Dutch
AGM 2021 Minutes (NL) (final) - Website(416948.1).pdf
AGM Information
2021-03-25 Dutch
Galapagos annual report 2020.pdf
Annual Report FY 2020
2021-03-25 English
Galapagos jaarverslag 2020.pdf
Annual Report FY 2020
2021-03-25 Dutch
AGM 2021 - convening notice EN_final.pdf
AGM Information
2021-03-25 English
AGM 2021 - convening notice NL_final.pdf
AGM Information
2021-03-25 Dutch
Galapagos annual report 2020.pdf
Annual Report FY 2020
2021-03-25 English
Galapagos jaarverslag 2020.pdf
Annual Report FY 2020
2021-03-25 Dutch
Galapagos appoints Bart Filius as President and Chief Operating Officer
Board/Management Information
2021-03-25 English
Galapagos appoints Bart Filius as President and Chief Operating Officer
Board/Management Information
2021-03-25 English
20-F Filing
Annual Report FY 2020
2021-03-25 English
6-K Filing
Foreign Filer Report
2021-03-25 English
6-K Filing
Foreign Filer Report
2021-03-25 English
Galapagos increases share capital through subscription right exercises
Share Issue/Capital Change
2021-03-22 English
Galapagos increases share capital through subscription right exercises
Declaration of Voting Results & Voting Rights Announcements
2021-03-22 English
6-K Filing
Foreign Filer Report
2021-03-22 English
Galapagos increases share capital through subscription right exercises.pdf
Declaration of Voting Results & Voting Rights Announcements
2021-03-19 English
Galapagos verhoogt kapitaal door uitoefening van inschrijvingsrechten.pdf
Share Issue/Capital Change
2021-03-19 Dutch
Transparency notification received from The Capital Group
Declaration of Voting Results & Voting Rights Announcements
2021-03-04 English
Transparency notification received from The Capital Group
Major Shareholding Notification
2021-03-04 English
GALAPAGOS REPORTS PRIMARY ENDPOINT FOR THE ONGOING FILGOTINIB MANTA AND MANTA-RAy SAFETY STUDIES
Earnings Release Q1 2021
2021-03-04 English
GALAPAGOS REPORTS PRIMARY ENDPOINT FOR THE ONGOING FILGOTINIB MANTA AND MANTA-RAy SAFETY STUDIES
Regulatory Filings
2021-03-04 English
GALAPAGOS REPORTS PRIMARY ENDPOINT FOR THE ONGOING FILGOTINIB MANTA AND MANTA-RAy SAFETY STUDIES
Regulatory Filings
2021-03-04 English
Galapagos kondigt primaire eindpunt aan van de lopende MANTA en MANTA-RAy veiligheidsstudies met filgotinib
Earnings Release Q1 2021
2021-03-04 Dutch
6-K Filing
Foreign Filer Report
2021-03-04 English
6-K Filing
Foreign Filer Report
2021-03-04 English
Transparency notification Capital.pdf
Major Shareholding Notification
2021-03-03 English
Transparency notification received from The Capital Group .pdf
Major Shareholding Notification
2021-03-03 English
Transparantieverklaring ontvangen van The Capital Group.pdf
Major Shareholding Notification
2021-03-03 Dutch
Pipeline and capital for growth
Earnings Release FY 2020
2021-02-19 English
Pipeline and capital for growth
Annual Report FY 2020
2021-02-19 English
Pijplijn en groeikapitaal
Earnings Release FY 2020
2021-02-19 Dutch
6-K Filing
Foreign Filer Report
2021-02-19 English
GLPG FY20 financial tables.pdf
Annual Report FY 2020
2021-02-18 English
GLPG 2020 financiele tabellen.pdf
Annual Report FY 2020
2021-02-18 Dutch
Pipeline and capital for growth.pdf
Earnings Release FY 2020
2021-02-18 English
Pijplijn en groeikapitaal.pdf
Earnings Release FY 2020
2021-02-18 Dutch
Galapagos and Gilead discontinue ISABELA Phase 3 trials in IPF
Regulatory Filings
2021-02-10 Dutch
Galapagos and Gilead discontinue ISABELA Phase 3 trials in IPF
Regulatory Filings
2021-02-10 English
Galapagos and Gilead discontinue ISABELA Phase 3 trials in IPF
Regulatory Filings
2021-02-10 English
Galapagos en Gilead zetten ISABELA Fase 3 studies in IPF stop
Regulatory Filings
2021-02-10 Dutch
The Capital Group holds 10.03% of Galapagos shares
Major Shareholding Notification
2021-02-10 English
The Capital Group holds 10.03% of Galapagos shares
Major Shareholding Notification
2021-02-10 Dutch
SC 13G Filing
Major Shareholding Notification
2021-02-10 English
SC 13G/A Filing
Major Shareholding Notification
2021-02-10 English
6-K Filing
Foreign Filer Report
2021-02-10 English
TR1_Galapagos NV_2021 01 22.pdf
Major Shareholding Notification
2021-02-09 English
The Capital Group holds 10.03% of Galapagos shares.pdf
Major Shareholding Notification
2021-02-09 English
The Capital Group bezit 10,03% van de Galapagos aandelen.pdf
Major Shareholding Notification
2021-02-09 Dutch
6-K Filing
Foreign Filer Report
2021-02-09 English
SC 13G/A Filing
Major Shareholding Notification
2021-01-29 English
NICE recommends Jyseleca® ?(filgotinib) on NHS in landmark decision for rheumatoid arthritis
Regulatory Filings
2021-01-21 English
NICE recommends Jyseleca® ?(filgotinib) on NHS in landmark decision for rheumatoid arthritis
Regulatory Filings
2021-01-21 English
6-K Filing
Foreign Filer Report
2021-01-21 English
Gilead holds 25.54% of Galapagos shares
Major Shareholding Notification
2021-01-12 Dutch
Gilead holds 25.54% of Galapagos shares
Major Shareholding Notification
2021-01-12 English
Gilead holds 25.54% of Galapagos shares.pdf
Major Shareholding Notification
2021-01-11 English
Gilead houdt 25,54% van de Galapagos aandelen.pdf
Major Shareholding Notification
2021-01-11 Dutch
6-K Filing
Foreign Filer Report
2021-01-11 English
Galapagos to present at 39th Annual J.P. Morgan Healthcare Conference
Report Publication Announcement
2021-01-06 English
Galapagos to present at 39th Annual J.P. Morgan Healthcare Conference
Investor Presentation
2021-01-06 English
6-K Filing
Foreign Filer Report
2021-01-06 English
Selvita completes acquisition of Fidelta from Galapagos
M&A Activity
2021-01-05 English
Selvita completes acquisition of Fidelta from Galapagos
M&A Activity
2021-01-05 English
6-K Filing
Foreign Filer Report
2021-01-05 English